Sunday, September 20, 2020

In Her Patients’ Shoes


www.strokecamp.org



http://www.unitedstrokealliance.org/


*****************************************************************


*****************************************************************

Article provided by Medtronic

Medtronic is a global leader in medical technology, services, and solutions. We collaborate with others to take on healthcare's greatest challenges.
https://www.medtronic.com


In Her Patients’ Shoes: Lisa’s Stroke Story

For more than 10 years, Lisa has been a stroke coordinator and cared for stroke patients in Wausau, Wisc., ensuring they get the best treatment and helping them in their recovery. She is a stroke expert.

One morning, in August 2017, Lisa learned even more about stroke: She learned what it was like to actually have one.

At the age of 51, Lisa was rushed to the hospital, her workplace, and the familiar faces of her coworkers were now treating her. Luckily Lisa received medical care quickly, but even then, she experienced several post-stroke conditions including facial droop and arm weakness. After several tests, her stroke care team couldn’t tell her what caused her stroke. Her stroke was a cryptogenic stroke, or a stroke of unknown cause.

In the months following her stroke, Lisa worked hard to recover — physically and mentally. She found her physical recovery to be progressing, but mentally, she was stressed. She didn’t know what caused her stroke and she didn’t know if, or when, it would happen again. Lisa, an independent and adventurous woman before her stroke, was scared and afraid to be alone.

Finding Peace of Mind — and Atrial Fibrillation

Lisa’s doctor suggested they use the Reveal LINQTM Insertable Cardiac Monitoring (ICM) System to monitor Lisa’s heart and determine if her stroke could have been caused by atrial fibrillation (AF). AF is a common condition in which the upper chambers of the heart beat very fast and irregularly. As a result, blood is not pumped effectively to the rest of the body and may pool and clot. If a clot dislodges, it can travel to the brain and result in a stroke. AF can happen infrequently and without symptoms and, when left untreated, AF patients have a five times higher chance of having a stroke.1

With the Reveal LINQ ICM continuously monitoring Lisa’s heart for irregular heart rhythms, Lisa found peace of mind and started gaining her independence back. She felt comfort knowing that if she was having irregular rhythms, her monitor would find them, and her doctor would be informed.

Almost one year later, the ICM detected AF and with the information from the monitor, Lisa’s doctor prescribed medication for Lisa to help prevent her AF from causing another stroke.

Lisa is now back to work and she immediately noticed her care for stroke patients has changed because of her experience — she can put herself in their shoes. She truly understands their fear, and she’s able to share her personal experiences of what helped her get through the challenges of stroke recovery.

To learn more about cardiac monitoring for unexplained, or cryptogenic, stroke, visit MonitorYourHeart.com
----------------------------------------------------------------------------------------------------
Treatment with a Reveal LINQ Insertable Cardiac Monitor is prescribed by your physician. This treatment is not for everyone. Please talk to your doctor to see if it is right for you. Your physician should discuss all potential benefits and risks with you. Although many patients benefit from the use of this treatment, results may vary. For further information, please call the Medtronic toll-free number at 1-800-551-5544 (7:00 a.m. to 7:00 p.m., Monday–Friday, Central Time) or see the Medtronic website at www.medtronic.com.

Reveal LINQ™ LNQ11 Insertable Cardiac Monitor and Patient Assistant

The Reveal LINQ insertable cardiac monitor is an implantable patient-activated and automatically-activated monitoring system that records subcutaneous ECG and is indicated in the following cases:

■ Patients with clinical syndromes or situations at increased risk of cardiac arrhythmias

■ Patients who experience transient symptoms such as dizziness, palpitation, syncope, and chest pain, that may suggest a cardiac arrhythmia

This device has not specifically been tested for pediatric use.

Patient Assistant
The Patient Assistant is intended for unsupervised patient use away from a hospital or clinic. The Patient Assistant activates the data management feature in the RevealTM insertable cardiac monitor to initiate recording of cardiac event data in the implanted device memory.

Contraindications
There are no known contraindications for the implant of the Reveal LINQ insertable cardiac monitor. However, the patient’s particular medical condition may dictate whether or not a subcutaneous, chronically implanted device can be tolerated.

Warnings and Precautions
Reveal LINQ LNQ11 Insertable Cardiac Monitor
Patients with the Reveal LINQ insertable cardiac monitor should avoid sources of diathermy, high sources of radiation, electrosurgical cautery, external defibrillation, lithotripsy, therapeutic ultrasound, and radiofrequency ablation to avoid electrical reset of the device, and/or inappropriate sensing as described in the Medical procedure and EMI precautions manual. MRI scans should be performed only in a specified MR environment under specified conditions as described in the Reveal LINQ MRI Technical Manual.

Patient Assistant
Operation of the Patient Assistant near sources of electromagnetic interference, such as cellular phones, computer monitors, etc., may adversely affect the performance of this device.

Potential Complications
Potential complications include, but are not limited to, device rejection phenomena (including local tissue reaction), device migration, infection, and erosion through the skin.

Medtronic MyCareLink™ Patient Monitor, Medtronic CareLink™ Network, and CareLink™ Mobile Application

Intended Use
The Medtronic MyCareLink patient monitor and CareLink network are indicated for use in the transfer of patient data from some Medtronic implantable cardiac devices based on physician instructions and as described in the product manual. The CareLink mobile application is intended to provide current CareLink network customers access to CareLink network data via a mobile device for their convenience. The CareLink mobile application is not replacing the full workstation, but can be used to review patient data when a physician does not have access to a workstation. These products are not a substitute for appropriate medical attention in the event of an emergency and should only be used as directed by a physician. CareLink network availability and mobile device accessibility may be unavailable at times due to maintenance or updates, or due to coverage being unavailable in your area. Mobile device access to the internet is required and subject to coverage availability. Standard text message rates apply.

Contraindications
There are no known contraindications.

Warnings and Precautions
The MyCareLink patient monitor must only be used for interrogating compatible Medtronic implantable devices.

See the device manual for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions, and potential complications/adverse events. For further information, please call Medtronic at 1-800-328-2518 and/or consult the Medtronic website at medtronic.com.

Caution: Federal law (USA) restricts these devices to sale by or on the order of a physician.

1 Fuster, et al. Journal of the American College of Cardiology. 2006; 48:854-906.
*****************************************************************

No comments:

Post a Comment

We would like to hear what you think of our articles and welcome your input. For your safety, all comments will be reviewed by the moderator before being posted. Please know that comments containing links to other sites or email addresses have typically been spam, so, and I apologize, comments containing those will be monitored closely and may not be accepted.